

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of female receptivity (GO:0045924) | 4.98649494 |
| 2 | female mating behavior (GO:0060180) | 4.64456414 |
| 3 | aggressive behavior (GO:0002118) | 4.45020794 |
| 4 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 4.36852630 |
| 5 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.25198494 |
| 6 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.24717128 |
| 7 | synaptic vesicle maturation (GO:0016188) | 4.08563592 |
| 8 | cell differentiation involved in metanephros development (GO:0072202) | 4.08444781 |
| 9 | endothelium development (GO:0003158) | 3.93513334 |
| 10 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.75956856 |
| 11 | detection of calcium ion (GO:0005513) | 3.74847215 |
| 12 | glutamate receptor signaling pathway (GO:0007215) | 3.68115969 |
| 13 | neuronal ion channel clustering (GO:0045161) | 3.67122421 |
| 14 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.60918096 |
| 15 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.54717167 |
| 16 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.48092333 |
| 17 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.48092333 |
| 18 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.46779076 |
| 19 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.40692098 |
| 20 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.37940485 |
| 21 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.27911070 |
| 22 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.27561601 |
| 23 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.26416226 |
| 24 | neuronal action potential propagation (GO:0019227) | 3.14310980 |
| 25 | vocalization behavior (GO:0071625) | 3.13621318 |
| 26 | synaptic transmission, glutamatergic (GO:0035249) | 3.12976434 |
| 27 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.10234465 |
| 28 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.09864059 |
| 29 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.09527487 |
| 30 | hyperosmotic salinity response (GO:0042538) | 3.08718420 |
| 31 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.03516294 |
| 32 | daunorubicin metabolic process (GO:0044597) | 3.03043221 |
| 33 | polyketide metabolic process (GO:0030638) | 3.03043221 |
| 34 | doxorubicin metabolic process (GO:0044598) | 3.03043221 |
| 35 | definitive hemopoiesis (GO:0060216) | 3.02230986 |
| 36 | presynaptic membrane assembly (GO:0097105) | 3.01000418 |
| 37 | neuron-neuron synaptic transmission (GO:0007270) | 3.00328522 |
| 38 | response to gravity (GO:0009629) | 2.99567773 |
| 39 | negative regulation of cation channel activity (GO:2001258) | 2.98432388 |
| 40 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.97378790 |
| 41 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.95942007 |
| 42 | cell volume homeostasis (GO:0006884) | 2.95925766 |
| 43 | protein localization to synapse (GO:0035418) | 2.94567657 |
| 44 | urogenital system development (GO:0001655) | 2.93439591 |
| 45 | regulation of skeletal muscle contraction (GO:0014819) | 2.92908571 |
| 46 | grooming behavior (GO:0007625) | 2.88471579 |
| 47 | neuron cell-cell adhesion (GO:0007158) | 2.85114412 |
| 48 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.83425292 |
| 49 | metanephric nephron tubule development (GO:0072234) | 2.83172594 |
| 50 | metanephric tubule development (GO:0072170) | 2.83172594 |
| 51 | positive regulation of odontogenesis (GO:0042482) | 2.81024338 |
| 52 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.80446216 |
| 53 | membrane depolarization during action potential (GO:0086010) | 2.78818276 |
| 54 | metanephric nephron epithelium development (GO:0072243) | 2.78364411 |
| 55 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.76536959 |
| 56 | righting reflex (GO:0060013) | 2.71458739 |
| 57 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.71400812 |
| 58 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.69981549 |
| 59 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.68216678 |
| 60 | long-term memory (GO:0007616) | 2.67710527 |
| 61 | blood vessel maturation (GO:0001955) | 2.65419700 |
| 62 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.65164774 |
| 63 | presynaptic membrane organization (GO:0097090) | 2.64779985 |
| 64 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.62818128 |
| 65 | regulation of cell communication by electrical coupling (GO:0010649) | 2.61694159 |
| 66 | metanephric mesenchyme development (GO:0072075) | 2.61609540 |
| 67 | locomotory exploration behavior (GO:0035641) | 2.60830100 |
| 68 | carnitine transmembrane transport (GO:1902603) | 2.59657581 |
| 69 | carnitine shuttle (GO:0006853) | 2.59553828 |
| 70 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.59339794 |
| 71 | calcium ion import (GO:0070509) | 2.57037558 |
| 72 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.57036603 |
| 73 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.56134347 |
| 74 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.54919054 |
| 75 | extracellular fibril organization (GO:0043206) | 2.52400970 |
| 76 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.52375862 |
| 77 | cell communication involved in cardiac conduction (GO:0086065) | 2.51626456 |
| 78 | nephron epithelium development (GO:0072009) | 2.51435357 |
| 79 | regulation of postsynaptic membrane potential (GO:0060078) | 2.51393683 |
| 80 | actin filament depolymerization (GO:0030042) | 2.51347106 |
| 81 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.50977099 |
| 82 | startle response (GO:0001964) | 2.50824659 |
| 83 | regulation of gonadotropin secretion (GO:0032276) | 2.50602322 |
| 84 | pattern specification involved in kidney development (GO:0061004) | 2.50586598 |
| 85 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.50562317 |
| 86 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.49588387 |
| 87 | metanephric epithelium development (GO:0072207) | 2.49521899 |
| 88 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.48746621 |
| 89 | synaptic vesicle exocytosis (GO:0016079) | 2.48743168 |
| 90 | receptor recycling (GO:0001881) | 2.47082113 |
| 91 | membrane depolarization (GO:0051899) | 2.44987686 |
| 92 | actin-myosin filament sliding (GO:0033275) | 2.44975505 |
| 93 | muscle filament sliding (GO:0030049) | 2.44975505 |
| 94 | indole-containing compound catabolic process (GO:0042436) | 2.44549337 |
| 95 | indolalkylamine catabolic process (GO:0046218) | 2.44549337 |
| 96 | tryptophan catabolic process (GO:0006569) | 2.44549337 |
| 97 | barbed-end actin filament capping (GO:0051016) | 2.43884939 |
| 98 | cAMP catabolic process (GO:0006198) | 2.43397360 |
| 99 | drinking behavior (GO:0042756) | 2.42949466 |
| 100 | postsynaptic membrane organization (GO:0001941) | 2.39954410 |
| 101 | positive regulation of glomerulus development (GO:0090193) | 2.38844967 |
| 102 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.38837547 |
| 103 | cardiac conduction (GO:0061337) | 2.38154238 |
| 104 | regulation of vesicle fusion (GO:0031338) | 2.38027317 |
| 105 | neuron recognition (GO:0008038) | 2.37125016 |
| 106 | positive regulation of digestive system process (GO:0060456) | 2.36657520 |
| 107 | sleep (GO:0030431) | 2.36229071 |
| 108 | cell communication by electrical coupling (GO:0010644) | 2.34472174 |
| 109 | regulation of glutamate secretion (GO:0014048) | 2.34385647 |
| 110 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.33850394 |
| 111 | multicellular organismal signaling (GO:0035637) | 2.32723309 |
| 112 | seminiferous tubule development (GO:0072520) | 2.32672857 |
| 113 | long term synaptic depression (GO:0060292) | 2.31917147 |
| 114 | positive regulation of cation channel activity (GO:2001259) | 2.31895364 |
| 115 | short-chain fatty acid metabolic process (GO:0046459) | 2.31704828 |
| 116 | behavioral response to cocaine (GO:0048148) | 2.31167233 |
| 117 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.30633710 |
| 118 | negative regulation of macrophage differentiation (GO:0045650) | 2.30608645 |
| 119 | cyclic nucleotide catabolic process (GO:0009214) | 2.30566785 |
| 120 | regulation of membrane repolarization (GO:0060306) | 2.30378921 |
| 121 | carnitine transport (GO:0015879) | 2.29592525 |
| 122 | amino-acid betaine transport (GO:0015838) | 2.29592525 |
| 123 | relaxation of cardiac muscle (GO:0055119) | 2.29410627 |
| 124 | cranial nerve morphogenesis (GO:0021602) | 2.29225336 |
| 125 | indole-containing compound metabolic process (GO:0042430) | 2.28882889 |
| 126 | deoxyribonucleotide catabolic process (GO:0009264) | 2.28716049 |
| 127 | negative regulation of cell size (GO:0045792) | 2.28246945 |
| 128 | aromatic amino acid family catabolic process (GO:0009074) | 2.28026993 |
| 129 | purine nucleotide salvage (GO:0032261) | 2.27717141 |
| 130 | serotonin metabolic process (GO:0042428) | 2.26793371 |
| 131 | tryptophan metabolic process (GO:0006568) | 2.26667428 |
| 132 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.26638615 |
| 133 | behavioral response to pain (GO:0048266) | 2.25801538 |
| 134 | transmission of nerve impulse (GO:0019226) | 2.25293474 |
| 135 | regulation of cardiac muscle contraction (GO:0055117) | 2.25092377 |
| 136 | neuronal action potential (GO:0019228) | 2.24915032 |
| 137 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.24639335 |
| 138 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.24546772 |
| 139 | positive regulation of action potential (GO:0045760) | 2.24429458 |
| 140 | glutamate secretion (GO:0014047) | 2.23370269 |
| 141 | kidney mesenchyme development (GO:0072074) | 2.23030868 |
| 142 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.21238827 |
| 143 | mitochondrion transport along microtubule (GO:0047497) | 2.21238827 |
| 144 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.20886605 |
| 145 | primary amino compound metabolic process (GO:1901160) | 2.20235984 |
| 146 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.19617770 |
| 147 | negative regulation of protein localization to cell surface (GO:2000009) | 2.19588286 |
| 148 | response to pain (GO:0048265) | 2.18987596 |
| 149 | fatty acid transmembrane transport (GO:1902001) | 2.18325302 |
| 150 | striatum development (GO:0021756) | 2.18181557 |
| 151 | protein maturation by protein folding (GO:0022417) | 2.17411862 |
| 152 | actin-mediated cell contraction (GO:0070252) | 2.17263836 |
| 153 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.17062639 |
| 154 | response to histamine (GO:0034776) | 2.16780953 |
| 155 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.16658034 |
| 156 | regulation of striated muscle contraction (GO:0006942) | 2.16074701 |
| 157 | quaternary ammonium group transport (GO:0015697) | 2.15873202 |
| 158 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.15541243 |
| 159 | long-term synaptic potentiation (GO:0060291) | 2.15483861 |
| 160 | exploration behavior (GO:0035640) | 2.15374285 |
| 161 | regulation of actin filament-based movement (GO:1903115) | 2.14818177 |
| 162 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.14479159 |
| 163 | cellular potassium ion transport (GO:0071804) | 2.14424081 |
| 164 | potassium ion transmembrane transport (GO:0071805) | 2.14424081 |
| 165 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.14330083 |
| 166 | nerve growth factor signaling pathway (GO:0038180) | 2.14173488 |
| 167 | cranial nerve structural organization (GO:0021604) | 2.13837279 |
| 168 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.13754038 |
| 169 | creatine metabolic process (GO:0006600) | 2.12910289 |
| 170 | prostaglandin biosynthetic process (GO:0001516) | 2.11920370 |
| 171 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.11715703 |
| 172 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.11715703 |
| 173 | cellular potassium ion homeostasis (GO:0030007) | 2.11709597 |
| 174 | axonal fasciculation (GO:0007413) | 2.11478686 |
| 175 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.10937342 |
| 176 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.10712609 |
| 177 | L-phenylalanine catabolic process (GO:0006559) | 2.10712609 |
| 178 | regulation of dendritic spine development (GO:0060998) | 2.10612325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.42826427 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.94742297 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.65567432 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.91676993 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.53067088 |
| 6 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.74520366 |
| 7 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.51703798 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.40396669 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.33050278 |
| 10 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.31123219 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.29553976 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.26094692 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.20571729 |
| 14 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.13026508 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.11082993 |
| 16 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.09013120 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.06662354 |
| 18 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.00104972 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.95762477 |
| 20 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.95494754 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.94322790 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.94245540 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.93736840 |
| 24 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.93080614 |
| 25 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.93080614 |
| 26 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.91583681 |
| 27 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.88541412 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.88250341 |
| 29 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.85979458 |
| 30 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.77691753 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.77221209 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.76209316 |
| 33 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.73988858 |
| 34 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.73524079 |
| 35 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.72746366 |
| 36 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.72542164 |
| 37 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.66510199 |
| 38 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.65930685 |
| 39 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.65189392 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.64413676 |
| 41 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.62829407 |
| 42 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.62707539 |
| 43 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.61603642 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58399492 |
| 45 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.57991076 |
| 46 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.57282526 |
| 47 | P68_20966046_ChIP-Seq_HELA_Human | 1.55752108 |
| 48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54153822 |
| 49 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.54031267 |
| 50 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.53641570 |
| 51 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.52780727 |
| 52 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.51435104 |
| 53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.51183595 |
| 54 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.50005709 |
| 55 | P300_19829295_ChIP-Seq_ESCs_Human | 1.49307368 |
| 56 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.49279424 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.47225701 |
| 58 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.47222699 |
| 59 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.46265604 |
| 60 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.46171679 |
| 61 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.45807382 |
| 62 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.41789064 |
| 63 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.40780385 |
| 64 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.39800704 |
| 65 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.39039896 |
| 66 | VDR_22108803_ChIP-Seq_LS180_Human | 1.38558852 |
| 67 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.38450928 |
| 68 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.35519285 |
| 69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.35243500 |
| 70 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.34251905 |
| 71 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.33568728 |
| 72 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.32619237 |
| 73 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.31260897 |
| 74 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.31259197 |
| 75 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29419302 |
| 76 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.29304342 |
| 77 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.28990060 |
| 78 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.28313336 |
| 79 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.28098931 |
| 80 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.27927350 |
| 81 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.25905629 |
| 82 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.25879919 |
| 83 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25672133 |
| 84 | STAT3_23295773_ChIP-Seq_U87_Human | 1.25189874 |
| 85 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.24993370 |
| 86 | KDM2B_26808549_Chip-Seq_K562_Human | 1.24585101 |
| 87 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.24041779 |
| 88 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.23480252 |
| 89 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.23219026 |
| 90 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.22133034 |
| 91 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.20089308 |
| 92 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.19550723 |
| 93 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.19492636 |
| 94 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.18704665 |
| 95 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.18704665 |
| 96 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.18174043 |
| 97 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.17639973 |
| 98 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17312936 |
| 99 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.16694708 |
| 100 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16694708 |
| 101 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16619610 |
| 102 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.16594840 |
| 103 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.16587086 |
| 104 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.16498068 |
| 105 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.16302860 |
| 106 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.15654676 |
| 107 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.15590650 |
| 108 | TCF4_23295773_ChIP-Seq_U87_Human | 1.15092528 |
| 109 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14828987 |
| 110 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.13300573 |
| 111 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.13159559 |
| 112 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.12607167 |
| 113 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.12462965 |
| 114 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.12240600 |
| 115 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.11603017 |
| 116 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11370271 |
| 117 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.10780068 |
| 118 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10711275 |
| 119 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10648128 |
| 120 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.10633172 |
| 121 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10630988 |
| 122 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.10372110 |
| 123 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09881311 |
| 124 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.09291612 |
| 125 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.09013133 |
| 126 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08926517 |
| 127 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.08149014 |
| 128 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07886395 |
| 129 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07427977 |
| 130 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.07402479 |
| 131 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06868161 |
| 132 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05935672 |
| 133 | TP53_16413492_ChIP-PET_HCT116_Human | 1.04896387 |
| 134 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.04875392 |
| 135 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04575224 |
| 136 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.03679033 |
| 137 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.03452982 |
| 138 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.02782814 |
| 139 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.02403463 |
| 140 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02354734 |
| 141 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02103932 |
| 142 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.01806488 |
| 143 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01643922 |
| 144 | KDM2B_26808549_Chip-Seq_REH_Human | 1.01395131 |
| 145 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01030432 |
| 146 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.00908715 |
| 147 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.00202127 |
| 148 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00005289 |
| 149 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.99902821 |
| 150 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99810363 |
| 151 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99500135 |
| 152 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98255781 |
| 153 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.97927442 |
| 154 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.97870228 |
| 155 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.97749774 |
| 156 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.97607258 |
| 157 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.96765603 |
| 158 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96733579 |
| 159 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96673066 |
| 160 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96563498 |
| 161 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96455113 |
| 162 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.95881570 |
| 163 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.95297925 |
| 164 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.93629641 |
| 165 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92711160 |
| 166 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.92064497 |
| 167 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.91806045 |
| 168 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.91445178 |
| 169 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.91402641 |
| 170 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.88345361 |
| 171 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.85948685 |
| 172 | * SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.85078913 |
| 173 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.83301902 |
| 174 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.83210262 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.06016972 |
| 2 | MP0003880_abnormal_central_pattern | 3.94600189 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 3.15860927 |
| 4 | MP0002822_catalepsy | 3.13593653 |
| 5 | MP0005670_abnormal_white_adipose | 3.12577909 |
| 6 | MP0000013_abnormal_adipose_tissue | 2.77028787 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 2.69304831 |
| 8 | MP0009745_abnormal_behavioral_response | 2.68855755 |
| 9 | MP0002735_abnormal_chemical_nociception | 2.55114553 |
| 10 | MP0010368_abnormal_lymphatic_system | 2.35889778 |
| 11 | MP0002876_abnormal_thyroid_physiology | 2.35740501 |
| 12 | MP0001188_hyperpigmentation | 2.32450613 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.24321916 |
| 14 | MP0002064_seizures | 2.15357188 |
| 15 | MP0003646_muscle_fatigue | 2.13183500 |
| 16 | MP0009278_abnormal_bone_marrow | 2.12378429 |
| 17 | MP0002139_abnormal_hepatobiliary_system | 2.09357776 |
| 18 | MP0002063_abnormal_learning/memory/cond | 2.08881454 |
| 19 | MP0001486_abnormal_startle_reflex | 2.05934051 |
| 20 | MP0002572_abnormal_emotion/affect_behav | 2.00882333 |
| 21 | MP0001545_abnormal_hematopoietic_system | 1.98905681 |
| 22 | MP0005397_hematopoietic_system_phenotyp | 1.98905681 |
| 23 | MP0001501_abnormal_sleep_pattern | 1.96315116 |
| 24 | MP0009046_muscle_twitch | 1.93639202 |
| 25 | MP0002272_abnormal_nervous_system | 1.93506844 |
| 26 | MP0005085_abnormal_gallbladder_physiolo | 1.93186416 |
| 27 | MP0002736_abnormal_nociception_after | 1.92948839 |
| 28 | MP0005666_abnormal_adipose_tissue | 1.91483847 |
| 29 | MP0000003_abnormal_adipose_tissue | 1.90646581 |
| 30 | MP0004215_abnormal_myocardial_fiber | 1.89183435 |
| 31 | MP0004043_abnormal_pH_regulation | 1.76792580 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.76735157 |
| 33 | MP0005409_darkened_coat_color | 1.76095669 |
| 34 | MP0003195_calcinosis | 1.75713888 |
| 35 | MP0005375_adipose_tissue_phenotype | 1.73918556 |
| 36 | MP0000751_myopathy | 1.69096118 |
| 37 | MP0003329_amyloid_beta_deposits | 1.68969862 |
| 38 | MP0001440_abnormal_grooming_behavior | 1.66177137 |
| 39 | MP0004270_analgesia | 1.65541532 |
| 40 | MP0004484_altered_response_of | 1.64521868 |
| 41 | MP0005646_abnormal_pituitary_gland | 1.64348771 |
| 42 | MP0001765_abnormal_ion_homeostasis | 1.59450241 |
| 43 | MP0001502_abnormal_circadian_rhythm | 1.59282683 |
| 44 | MP0003279_aneurysm | 1.59184739 |
| 45 | MP0009840_abnormal_foam_cell | 1.55267024 |
| 46 | MP0002067_abnormal_sensory_capabilities | 1.54986244 |
| 47 | MP0004145_abnormal_muscle_electrophysio | 1.49962958 |
| 48 | MP0002971_abnormal_brown_adipose | 1.46445258 |
| 49 | MP0005360_urolithiasis | 1.46291234 |
| 50 | MP0000749_muscle_degeneration | 1.37728447 |
| 51 | MP0003075_altered_response_to | 1.37512511 |
| 52 | MP0008875_abnormal_xenobiotic_pharmacok | 1.37080188 |
| 53 | MP0003879_abnormal_hair_cell | 1.36545724 |
| 54 | MP0004142_abnormal_muscle_tone | 1.32871052 |
| 55 | MP0002653_abnormal_ependyma_morphology | 1.32636893 |
| 56 | MP0005365_abnormal_bile_salt | 1.31370003 |
| 57 | MP0004036_abnormal_muscle_relaxation | 1.31123754 |
| 58 | MP0005645_abnormal_hypothalamus_physiol | 1.31039362 |
| 59 | MP0002734_abnormal_mechanical_nocicepti | 1.28890450 |
| 60 | MP0004087_abnormal_muscle_fiber | 1.28785927 |
| 61 | MP0005451_abnormal_body_composition | 1.27992529 |
| 62 | MP0003137_abnormal_impulse_conducting | 1.27012919 |
| 63 | MP0000681_abnormal_thyroid_gland | 1.25521505 |
| 64 | MP0004084_abnormal_cardiac_muscle | 1.24928389 |
| 65 | MP0001970_abnormal_pain_threshold | 1.23465241 |
| 66 | MP0000759_abnormal_skeletal_muscle | 1.23249013 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 1.23131443 |
| 68 | MP0008569_lethality_at_weaning | 1.22956432 |
| 69 | MP0003172_abnormal_lysosome_physiology | 1.22950577 |
| 70 | MP0005535_abnormal_body_temperature | 1.22782645 |
| 71 | MP0002557_abnormal_social/conspecific_i | 1.21911079 |
| 72 | MP0002909_abnormal_adrenal_gland | 1.21295391 |
| 73 | MP0008775_abnormal_heart_ventricle | 1.20608068 |
| 74 | MP0009780_abnormal_chondrocyte_physiolo | 1.20333230 |
| 75 | MP0006036_abnormal_mitochondrial_physio | 1.20328954 |
| 76 | MP0006138_congestive_heart_failure | 1.18848227 |
| 77 | MP0010386_abnormal_urinary_bladder | 1.15716260 |
| 78 | MP0005620_abnormal_muscle_contractility | 1.13879166 |
| 79 | MP0002733_abnormal_thermal_nociception | 1.13202546 |
| 80 | MP0002138_abnormal_hepatobiliary_system | 1.12790601 |
| 81 | MP0005423_abnormal_somatic_nervous | 1.11762485 |
| 82 | MP0004510_myositis | 1.11708776 |
| 83 | MP0004085_abnormal_heartbeat | 1.10782558 |
| 84 | MP0001529_abnormal_vocalization | 1.10219349 |
| 85 | MP0001905_abnormal_dopamine_level | 1.09965197 |
| 86 | MP0004019_abnormal_vitamin_homeostasis | 1.07347119 |
| 87 | MP0003252_abnormal_bile_duct | 1.06813122 |
| 88 | MP0005332_abnormal_amino_acid | 1.06110131 |
| 89 | MP0008789_abnormal_olfactory_epithelium | 1.05768131 |
| 90 | MP0001984_abnormal_olfaction | 1.04004264 |
| 91 | MP0003868_abnormal_feces_composition | 1.03406374 |
| 92 | MP0006276_abnormal_autonomic_nervous | 1.01096703 |
| 93 | MP0004924_abnormal_behavior | 1.00123965 |
| 94 | MP0005386_behavior/neurological_phenoty | 1.00123965 |
| 95 | MP0003136_yellow_coat_color | 0.98625056 |
| 96 | MP0008874_decreased_physiological_sensi | 0.98126997 |
| 97 | MP0005394_taste/olfaction_phenotype | 0.96712125 |
| 98 | MP0005499_abnormal_olfactory_system | 0.96712125 |
| 99 | MP0001666_abnormal_nutrient_absorption | 0.96308111 |
| 100 | MP0008872_abnormal_physiological_respon | 0.95773029 |
| 101 | MP0005330_cardiomyopathy | 0.94888729 |
| 102 | MP0003283_abnormal_digestive_organ | 0.93185159 |
| 103 | MP0003828_pulmonary_edema | 0.92170085 |
| 104 | MP0002972_abnormal_cardiac_muscle | 0.91446929 |
| 105 | MP0004742_abnormal_vestibular_system | 0.90895715 |
| 106 | MP0005551_abnormal_eye_electrophysiolog | 0.90362252 |
| 107 | MP0002332_abnormal_exercise_endurance | 0.89373525 |
| 108 | MP0008004_abnormal_stomach_pH | 0.89331349 |
| 109 | MP0003690_abnormal_glial_cell | 0.88972901 |
| 110 | MP0002106_abnormal_muscle_physiology | 0.88633928 |
| 111 | MP0002066_abnormal_motor_capabilities/c | 0.88235719 |
| 112 | MP0006292_abnormal_olfactory_placode | 0.85938758 |
| 113 | MP0000750_abnormal_muscle_regeneration | 0.85809974 |
| 114 | MP0001664_abnormal_digestion | 0.85114229 |
| 115 | MP0009384_cardiac_valve_regurgitation | 0.84558685 |
| 116 | MP0003633_abnormal_nervous_system | 0.84546361 |
| 117 | MP0000343_altered_response_to | 0.84501215 |
| 118 | MP0000747_muscle_weakness | 0.84089948 |
| 119 | MP0001756_abnormal_urination | 0.83895318 |
| 120 | MP0005636_abnormal_mineral_homeostasis | 0.80838377 |
| 121 | MP0002184_abnormal_innervation | 0.80130981 |
| 122 | MP0003123_paternal_imprinting | 0.79886009 |
| 123 | MP0000566_synostosis | 0.79864233 |
| 124 | MP0002269_muscular_atrophy | 0.79405134 |
| 125 | MP0005171_absent_coat_pigmentation | 0.78799949 |
| 126 | MP0000569_abnormal_digit_pigmentation | 0.78707523 |
| 127 | MP0005084_abnormal_gallbladder_morpholo | 0.78690725 |
| 128 | MP0005334_abnormal_fat_pad | 0.78510556 |
| 129 | MP0005058_abnormal_lysosome_morphology | 0.78167212 |
| 130 | MP0000230_abnormal_systemic_arterial | 0.78125601 |
| 131 | MP0001879_abnormal_lymphatic_vessel | 0.77397455 |
| 132 | MP0005595_abnormal_vascular_smooth | 0.77314286 |
| 133 | MP0004130_abnormal_muscle_cell | 0.75802379 |
| 134 | MP0002069_abnormal_eating/drinking_beha | 0.75563159 |
| 135 | MP0005083_abnormal_biliary_tract | 0.74398317 |
| 136 | MP0003045_fibrosis | 0.73935826 |
| 137 | MP0002229_neurodegeneration | 0.73898784 |
| 138 | MP0002078_abnormal_glucose_homeostasis | 0.73713945 |
| 139 | MP0003787_abnormal_imprinting | 0.72510288 |
| 140 | MP0004381_abnormal_hair_follicle | 0.72006661 |
| 141 | MP0001963_abnormal_hearing_physiology | 0.69460175 |
| 142 | MP0009379_abnormal_foot_pigmentation | 0.69099081 |
| 143 | MP0000778_abnormal_nervous_system | 0.68895779 |
| 144 | MP0001485_abnormal_pinna_reflex | 0.68236258 |
| 145 | MP0002638_abnormal_pupillary_reflex | 0.67958770 |
| 146 | MP0005165_increased_susceptibility_to | 0.67172895 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.13595389 |
| 2 | Febrile seizures (HP:0002373) | 4.16253940 |
| 3 | Rhabdomyolysis (HP:0003201) | 3.95420848 |
| 4 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.71848674 |
| 5 | Exercise-induced myalgia (HP:0003738) | 3.61267020 |
| 6 | Hyperactive renin-angiotensin system (HP:0000841) | 3.60873236 |
| 7 | Syncope (HP:0001279) | 3.59922654 |
| 8 | Decreased circulating renin level (HP:0003351) | 3.59294385 |
| 9 | Sudden death (HP:0001699) | 3.50562793 |
| 10 | Increased circulating renin level (HP:0000848) | 3.49454008 |
| 11 | Muscle stiffness (HP:0003552) | 3.40327487 |
| 12 | Hyperkalemia (HP:0002153) | 3.30597723 |
| 13 | Hyperventilation (HP:0002883) | 3.25129459 |
| 14 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.18041969 |
| 15 | Focal seizures (HP:0007359) | 3.14674524 |
| 16 | Prolonged QT interval (HP:0001657) | 3.12811939 |
| 17 | Metaphyseal dysplasia (HP:0100255) | 3.09577689 |
| 18 | Atrial fibrillation (HP:0005110) | 3.07660058 |
| 19 | Calf muscle hypertrophy (HP:0008981) | 3.04687344 |
| 20 | Supranuclear gaze palsy (HP:0000605) | 3.03356841 |
| 21 | Metabolic alkalosis (HP:0200114) | 2.91748665 |
| 22 | Myokymia (HP:0002411) | 2.91060837 |
| 23 | Epileptic encephalopathy (HP:0200134) | 2.89442265 |
| 24 | Primary atrial arrhythmia (HP:0001692) | 2.87460307 |
| 25 | Hyperaldosteronism (HP:0000859) | 2.80099518 |
| 26 | Generalized tonic-clonic seizures (HP:0002069) | 2.79429217 |
| 27 | Abnormality of renin-angiotensin system (HP:0000847) | 2.74738184 |
| 28 | EMG: myopathic abnormalities (HP:0003458) | 2.68020946 |
| 29 | Asymmetric septal hypertrophy (HP:0001670) | 2.67974794 |
| 30 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.67039098 |
| 31 | Broad-based gait (HP:0002136) | 2.64999814 |
| 32 | Supraventricular tachycardia (HP:0004755) | 2.64971802 |
| 33 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.64599574 |
| 34 | Increased variability in muscle fiber diameter (HP:0003557) | 2.64492689 |
| 35 | Muscle fiber splitting (HP:0003555) | 2.63997099 |
| 36 | Abnormal EKG (HP:0003115) | 2.63322134 |
| 37 | Increased muscle lipid content (HP:0009058) | 2.62263874 |
| 38 | Growth hormone excess (HP:0000845) | 2.59899804 |
| 39 | Ketoacidosis (HP:0001993) | 2.59503408 |
| 40 | Joint stiffness (HP:0001387) | 2.57244178 |
| 41 | Atonic seizures (HP:0010819) | 2.56147587 |
| 42 | Supraventricular arrhythmia (HP:0005115) | 2.51883200 |
| 43 | Congenital sensorineural hearing impairment (HP:0008527) | 2.51491377 |
| 44 | Myotonia (HP:0002486) | 2.49337671 |
| 45 | Ragged-red muscle fibers (HP:0003200) | 2.48219068 |
| 46 | Fair hair (HP:0002286) | 2.46771364 |
| 47 | Protrusio acetabuli (HP:0003179) | 2.46259999 |
| 48 | Nemaline bodies (HP:0003798) | 2.45067840 |
| 49 | Hypomagnesemia (HP:0002917) | 2.44212433 |
| 50 | Spinal rigidity (HP:0003306) | 2.40436701 |
| 51 | Muscle fiber inclusion bodies (HP:0100299) | 2.40306631 |
| 52 | Renal cortical cysts (HP:0000803) | 2.38140021 |
| 53 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.37496289 |
| 54 | Ventricular fibrillation (HP:0001663) | 2.37414674 |
| 55 | Dialeptic seizures (HP:0011146) | 2.33851749 |
| 56 | Acute encephalopathy (HP:0006846) | 2.33278778 |
| 57 | Hyporeflexia of lower limbs (HP:0002600) | 2.33070608 |
| 58 | Bradycardia (HP:0001662) | 2.32437612 |
| 59 | Difficulty climbing stairs (HP:0003551) | 2.30233647 |
| 60 | Absence seizures (HP:0002121) | 2.29537782 |
| 61 | Ventricular arrhythmia (HP:0004308) | 2.28130067 |
| 62 | Ketosis (HP:0001946) | 2.27324131 |
| 63 | Abnormal atrioventricular conduction (HP:0005150) | 2.26593087 |
| 64 | Acute necrotizing encephalopathy (HP:0006965) | 2.26027196 |
| 65 | Dysdiadochokinesis (HP:0002075) | 2.25895285 |
| 66 | Bundle branch block (HP:0011710) | 2.25452962 |
| 67 | Generalized hypopigmentation of hair (HP:0011358) | 2.22259297 |
| 68 | Abnormality of chloride homeostasis (HP:0011422) | 2.22185769 |
| 69 | Cervical subluxation (HP:0003308) | 2.21036319 |
| 70 | Abnormality of potassium homeostasis (HP:0011042) | 2.20890563 |
| 71 | Cerebral palsy (HP:0100021) | 2.19510573 |
| 72 | Prolonged partial thromboplastin time (HP:0003645) | 2.16691469 |
| 73 | Abnormality of macular pigmentation (HP:0008002) | 2.15744166 |
| 74 | Type 1 muscle fiber predominance (HP:0003803) | 2.14938182 |
| 75 | Neck muscle weakness (HP:0000467) | 2.14700339 |
| 76 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.14091129 |
| 77 | Methylmalonic acidemia (HP:0002912) | 2.12786243 |
| 78 | Axonal loss (HP:0003447) | 2.12742014 |
| 79 | Conjugated hyperbilirubinemia (HP:0002908) | 2.11248119 |
| 80 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.10896004 |
| 81 | Joint hemorrhage (HP:0005261) | 2.08884508 |
| 82 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.08371464 |
| 83 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.08371464 |
| 84 | Distal lower limb amyotrophy (HP:0008944) | 2.07826001 |
| 85 | Abnormality of the calf musculature (HP:0001430) | 2.06889593 |
| 86 | Nuclear cataract (HP:0100018) | 2.06874355 |
| 87 | Gaze-evoked nystagmus (HP:0000640) | 2.06667143 |
| 88 | Progressive macrocephaly (HP:0004481) | 2.06200748 |
| 89 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.06068250 |
| 90 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.06068250 |
| 91 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.06068250 |
| 92 | Insulin resistance (HP:0000855) | 2.04234471 |
| 93 | Cerebral edema (HP:0002181) | 2.03907766 |
| 94 | Status epilepticus (HP:0002133) | 2.03116252 |
| 95 | Abnormality of magnesium homeostasis (HP:0004921) | 2.01965971 |
| 96 | Dilated cardiomyopathy (HP:0001644) | 2.01227535 |
| 97 | Confusion (HP:0001289) | 2.01173114 |
| 98 | Myopathic facies (HP:0002058) | 2.01139425 |
| 99 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.00861794 |
| 100 | Central scotoma (HP:0000603) | 2.00738702 |
| 101 | Rimmed vacuoles (HP:0003805) | 2.00606466 |
| 102 | Ventricular tachycardia (HP:0004756) | 1.99621416 |
| 103 | Absent/shortened dynein arms (HP:0200106) | 1.99485856 |
| 104 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.99485856 |
| 105 | Vertebral compression fractures (HP:0002953) | 1.98056917 |
| 106 | Tubulointerstitial nephritis (HP:0001970) | 1.97901241 |
| 107 | Oligomenorrhea (HP:0000876) | 1.97782214 |
| 108 | Neurofibrillary tangles (HP:0002185) | 1.97292598 |
| 109 | Myoglobinuria (HP:0002913) | 1.97143787 |
| 110 | Tetany (HP:0001281) | 1.96617450 |
| 111 | Exotropia (HP:0000577) | 1.95502743 |
| 112 | Increased intramyocellular lipid droplets (HP:0012240) | 1.95308119 |
| 113 | Abnormality of the lower motor neuron (HP:0002366) | 1.95279732 |
| 114 | Abnormality of renal resorption (HP:0011038) | 1.94435528 |
| 115 | Vascular calcification (HP:0004934) | 1.94322589 |
| 116 | Mitochondrial inheritance (HP:0001427) | 1.93603492 |
| 117 | Heart block (HP:0012722) | 1.93591505 |
| 118 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.92841310 |
| 119 | Protruding tongue (HP:0010808) | 1.90508669 |
| 120 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.88909689 |
| 121 | Mucopolysacchariduria (HP:0008155) | 1.88909689 |
| 122 | EMG: neuropathic changes (HP:0003445) | 1.88806653 |
| 123 | Limb-girdle muscle atrophy (HP:0003797) | 1.88806449 |
| 124 | Metabolic acidosis (HP:0001942) | 1.88068450 |
| 125 | Hyperglycinuria (HP:0003108) | 1.86668000 |
| 126 | Dysmetria (HP:0001310) | 1.86605546 |
| 127 | Hypokalemic alkalosis (HP:0001949) | 1.86431158 |
| 128 | Gout (HP:0001997) | 1.85814276 |
| 129 | Gowers sign (HP:0003391) | 1.84767727 |
| 130 | Lipoatrophy (HP:0100578) | 1.84228690 |
| 131 | Reduced antithrombin III activity (HP:0001976) | 1.83717135 |
| 132 | Amyloidosis (HP:0011034) | 1.83032246 |
| 133 | Absent speech (HP:0001344) | 1.82337372 |
| 134 | Abnormal drinking behavior (HP:0030082) | 1.82259439 |
| 135 | Polydipsia (HP:0001959) | 1.82259439 |
| 136 | Visual hallucinations (HP:0002367) | 1.82243113 |
| 137 | Testicular atrophy (HP:0000029) | 1.81834781 |
| 138 | Hepatic necrosis (HP:0002605) | 1.80692201 |
| 139 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.80193508 |
| 140 | Progressive cerebellar ataxia (HP:0002073) | 1.79452048 |
| 141 | Abnormal ciliary motility (HP:0012262) | 1.79150689 |
| 142 | Abnormality of the periventricular white matter (HP:0002518) | 1.79131679 |
| 143 | Renal Fanconi syndrome (HP:0001994) | 1.79122963 |
| 144 | Scapular winging (HP:0003691) | 1.79073878 |
| 145 | Alkalosis (HP:0001948) | 1.78040506 |
| 146 | Dysostosis multiplex (HP:0000943) | 1.78031051 |
| 147 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.77899804 |
| 148 | Abnormality of alanine metabolism (HP:0010916) | 1.77899804 |
| 149 | Hyperalaninemia (HP:0003348) | 1.77899804 |
| 150 | Abnormal eating behavior (HP:0100738) | 1.77174662 |
| 151 | Distal lower limb muscle weakness (HP:0009053) | 1.75935000 |
| 152 | Short nail (HP:0001799) | 1.75910876 |
| 153 | Anxiety (HP:0000739) | 1.75586646 |
| 154 | Left ventricular hypertrophy (HP:0001712) | 1.75257971 |
| 155 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.74641299 |
| 156 | Subaortic stenosis (HP:0001682) | 1.74641299 |
| 157 | Hepatocellular necrosis (HP:0001404) | 1.74490390 |
| 158 | Dicarboxylic aciduria (HP:0003215) | 1.73513829 |
| 159 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.73513829 |
| 160 | Increased connective tissue (HP:0009025) | 1.72742913 |
| 161 | Male infertility (HP:0003251) | 1.71973810 |
| 162 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.71208595 |
| 163 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.71108339 |
| 164 | Polar cataract (HP:0010696) | 1.70783000 |
| 165 | Optic disc pallor (HP:0000543) | 1.70698767 |
| 166 | Lower limb amyotrophy (HP:0007210) | 1.69963271 |
| 167 | Abnormality of glycolipid metabolism (HP:0010969) | 1.69211835 |
| 168 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.69211835 |
| 169 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.69211835 |
| 170 | Abnormality of the renal cortex (HP:0011035) | 1.68695345 |
| 171 | Intention tremor (HP:0002080) | 1.67742981 |
| 172 | Aortic regurgitation (HP:0001659) | 1.67599758 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.80398758 |
| 2 | EPHA4 | 4.08590436 |
| 3 | TNIK | 3.87040389 |
| 4 | TESK1 | 3.01532381 |
| 5 | CASK | 2.77328038 |
| 6 | ERN1 | 2.71898779 |
| 7 | RIPK4 | 2.59654553 |
| 8 | PRPF4B | 2.54605409 |
| 9 | ARAF | 2.52418766 |
| 10 | PIM2 | 2.46804221 |
| 11 | MAP3K11 | 2.40596691 |
| 12 | INSRR | 2.34606188 |
| 13 | MAP2K7 | 2.33861430 |
| 14 | TIE1 | 2.16747874 |
| 15 | FLT3 | 2.14609236 |
| 16 | LIMK1 | 1.87701002 |
| 17 | EPHA3 | 1.82867262 |
| 18 | MAPK15 | 1.77690502 |
| 19 | NME2 | 1.68538440 |
| 20 | MAP3K4 | 1.68465998 |
| 21 | PINK1 | 1.67927884 |
| 22 | BMPR2 | 1.66415906 |
| 23 | PHKG1 | 1.65665507 |
| 24 | PHKG2 | 1.65665507 |
| 25 | TTN | 1.63862721 |
| 26 | SCYL2 | 1.62865107 |
| 27 | KDR | 1.52536475 |
| 28 | MAP3K13 | 1.49596975 |
| 29 | MAP2K3 | 1.48985206 |
| 30 | MARK2 | 1.47338496 |
| 31 | ABL2 | 1.45962047 |
| 32 | VRK2 | 1.44779044 |
| 33 | DAPK2 | 1.44462996 |
| 34 | TESK2 | 1.42612770 |
| 35 | EPHA2 | 1.42583979 |
| 36 | OBSCN | 1.34682856 |
| 37 | DAPK3 | 1.32565912 |
| 38 | MARK1 | 1.31446469 |
| 39 | MAP2K4 | 1.30345105 |
| 40 | MAP3K14 | 1.26917977 |
| 41 | MUSK | 1.24740554 |
| 42 | WNK4 | 1.22579127 |
| 43 | SGK2 | 1.22430539 |
| 44 | LMTK2 | 1.21985352 |
| 45 | CAMK2A | 1.20857138 |
| 46 | KIT | 1.20410662 |
| 47 | FES | 1.19962890 |
| 48 | NME1 | 1.18304738 |
| 49 | RIPK1 | 1.14986441 |
| 50 | GRK7 | 1.14460221 |
| 51 | OXSR1 | 1.14308205 |
| 52 | STK38 | 1.12753914 |
| 53 | SGK494 | 1.10555285 |
| 54 | SGK223 | 1.10555285 |
| 55 | NTRK1 | 1.07450736 |
| 56 | WNK3 | 1.03746118 |
| 57 | MOS | 1.02640019 |
| 58 | DYRK1B | 1.02420646 |
| 59 | EPHB2 | 1.02407029 |
| 60 | SIK2 | 0.99553721 |
| 61 | MST1R | 0.98388091 |
| 62 | PKN1 | 0.97522113 |
| 63 | IRAK3 | 0.96159769 |
| 64 | CAMK2B | 0.95738689 |
| 65 | CAMK1 | 0.93551043 |
| 66 | CAMK2D | 0.92404822 |
| 67 | MAPK13 | 0.92379616 |
| 68 | TBK1 | 0.91146672 |
| 69 | PRKCE | 0.90993671 |
| 70 | SGK1 | 0.89845205 |
| 71 | MAP3K6 | 0.88639061 |
| 72 | ZAK | 0.88372515 |
| 73 | CDK19 | 0.88198725 |
| 74 | SIK3 | 0.87504219 |
| 75 | PTK2 | 0.87176678 |
| 76 | MAP3K12 | 0.86496290 |
| 77 | MINK1 | 0.86364197 |
| 78 | PRKCQ | 0.85902200 |
| 79 | CAMKK2 | 0.85230121 |
| 80 | SGK3 | 0.84897475 |
| 81 | MAP3K7 | 0.83287877 |
| 82 | PRKD2 | 0.83271514 |
| 83 | MAP2K6 | 0.82804417 |
| 84 | NLK | 0.82521331 |
| 85 | GRK1 | 0.81673991 |
| 86 | IRAK1 | 0.81105283 |
| 87 | CDK3 | 0.80859460 |
| 88 | DMPK | 0.77785042 |
| 89 | STK39 | 0.76591861 |
| 90 | TGFBR2 | 0.76234010 |
| 91 | CAMK2G | 0.74864082 |
| 92 | AKT3 | 0.73438617 |
| 93 | NTRK2 | 0.72344875 |
| 94 | CDK5 | 0.72042428 |
| 95 | BCKDK | 0.71813052 |
| 96 | PTK2B | 0.70777087 |
| 97 | CCNB1 | 0.70181598 |
| 98 | PRKCG | 0.69207168 |
| 99 | BRD4 | 0.68832719 |
| 100 | MYLK | 0.67959265 |
| 101 | JAK1 | 0.67691911 |
| 102 | PRKAA2 | 0.67358667 |
| 103 | MAP3K9 | 0.66942251 |
| 104 | HIPK2 | 0.66720316 |
| 105 | PIK3CG | 0.65790479 |
| 106 | TAOK2 | 0.65697519 |
| 107 | CDK9 | 0.65549469 |
| 108 | CAMK4 | 0.65120311 |
| 109 | TRPM7 | 0.65016353 |
| 110 | MAP4K2 | 0.64995145 |
| 111 | EPHB1 | 0.62957786 |
| 112 | PIK3CA | 0.62701636 |
| 113 | UHMK1 | 0.62629074 |
| 114 | TNK2 | 0.62413445 |
| 115 | GRK5 | 0.62202185 |
| 116 | WNK1 | 0.61921120 |
| 117 | MAP3K1 | 0.61068708 |
| 118 | EIF2AK2 | 0.60576047 |
| 119 | CDC42BPA | 0.59338756 |
| 120 | KSR1 | 0.58912632 |
| 121 | TXK | 0.57869513 |
| 122 | MET | 0.57582506 |
| 123 | TAOK3 | 0.57323329 |
| 124 | MAPK12 | 0.56386191 |
| 125 | NEK6 | 0.56306516 |
| 126 | PAK3 | 0.55518431 |
| 127 | PRKD1 | 0.54942523 |
| 128 | RPS6KA2 | 0.54079004 |
| 129 | ADRBK2 | 0.53723717 |
| 130 | PRKACA | 0.53138944 |
| 131 | PRKG2 | 0.52580845 |
| 132 | PAK6 | 0.52090724 |
| 133 | CAMKK1 | 0.52025207 |
| 134 | STK11 | 0.51727553 |
| 135 | PDPK1 | 0.51436171 |
| 136 | MAPK4 | 0.50481591 |
| 137 | RPS6KC1 | 0.50051907 |
| 138 | RPS6KL1 | 0.50051907 |
| 139 | FRK | 0.49564310 |
| 140 | BMX | 0.48936305 |
| 141 | FGR | 0.48551805 |
| 142 | IKBKE | 0.48291616 |
| 143 | PLK2 | 0.48262901 |
| 144 | DAPK1 | 0.47733140 |
| 145 | FGFR4 | 0.46313567 |
| 146 | SIK1 | 0.46274122 |
| 147 | IRAK4 | 0.44818265 |
| 148 | SYK | 0.44549008 |
| 149 | BLK | 0.44438461 |
| 150 | ROCK1 | 0.44069634 |
| 151 | CSF1R | 0.40575562 |
| 152 | SRC | 0.38983002 |
| 153 | MAP3K5 | 0.38629656 |
| 154 | RPS6KA6 | 0.38037767 |
| 155 | ILK | 0.37971611 |
| 156 | RAF1 | 0.35971161 |
| 157 | DYRK1A | 0.35622381 |
| 158 | BRAF | 0.35379936 |
| 159 | LATS2 | 0.33514945 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.20313016 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.32199623 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.24412838 |
| 4 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.20121872 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.16052805 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.10326759 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.01508660 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.93860288 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 1.88222248 |
| 10 | Taste transduction_Homo sapiens_hsa04742 | 1.87247201 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 1.78013698 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 1.75536610 |
| 13 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.74402718 |
| 14 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.74160919 |
| 15 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.72791949 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.71204367 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.62001040 |
| 18 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.59650581 |
| 19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.58836558 |
| 20 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.58015714 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 1.55004816 |
| 22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.52675525 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.48812812 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.47490718 |
| 25 | Sulfur relay system_Homo sapiens_hsa04122 | 1.47144788 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.43741783 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.41951096 |
| 28 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.37226450 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.28972832 |
| 30 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.28399019 |
| 31 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.24907807 |
| 32 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.24759406 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.24440203 |
| 34 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.22927986 |
| 35 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.22812993 |
| 36 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.19921294 |
| 37 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.19407427 |
| 38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.18701091 |
| 39 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.17892036 |
| 40 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.14628834 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.14263051 |
| 42 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.14064664 |
| 43 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.12470606 |
| 44 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.12015529 |
| 45 | Cocaine addiction_Homo sapiens_hsa05030 | 1.11338408 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11265036 |
| 47 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.07366644 |
| 48 | Parkinsons disease_Homo sapiens_hsa05012 | 1.05628630 |
| 49 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.00502504 |
| 50 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.99830866 |
| 51 | Long-term depression_Homo sapiens_hsa04730 | 0.99757967 |
| 52 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.99321053 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.98978702 |
| 54 | * Carbon metabolism_Homo sapiens_hsa01200 | 0.98907379 |
| 55 | Histidine metabolism_Homo sapiens_hsa00340 | 0.97258682 |
| 56 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.97151978 |
| 57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.92660683 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 0.92627447 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.92420071 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.91256807 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90341644 |
| 62 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.90267521 |
| 63 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.89375420 |
| 64 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.88957598 |
| 65 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.88079906 |
| 66 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.85582847 |
| 67 | Peroxisome_Homo sapiens_hsa04146 | 0.84700263 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83454163 |
| 69 | Bile secretion_Homo sapiens_hsa04976 | 0.83136506 |
| 70 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82531790 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81809300 |
| 72 | Circadian rhythm_Homo sapiens_hsa04710 | 0.80989815 |
| 73 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78638852 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78255244 |
| 75 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.78106235 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77808052 |
| 77 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.77303921 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.76853215 |
| 79 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.76237208 |
| 80 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.76137058 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.75620490 |
| 82 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.75069665 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73470222 |
| 84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.70361812 |
| 85 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.70240686 |
| 86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69045541 |
| 87 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.68319210 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68042766 |
| 89 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.67979272 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66172753 |
| 91 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.65993435 |
| 92 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.65764068 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63879570 |
| 94 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63803923 |
| 95 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.63653716 |
| 96 | Lysosome_Homo sapiens_hsa04142 | 0.63184979 |
| 97 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.62480508 |
| 98 | Platelet activation_Homo sapiens_hsa04611 | 0.58981327 |
| 99 | Gap junction_Homo sapiens_hsa04540 | 0.58160859 |
| 100 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.57255852 |
| 101 | Huntingtons disease_Homo sapiens_hsa05016 | 0.56802966 |
| 102 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55083838 |
| 103 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.54098646 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53488304 |
| 105 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.52182755 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50999138 |
| 107 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.50876909 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50659244 |
| 109 | * Pyruvate metabolism_Homo sapiens_hsa00620 | 0.49983234 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48640039 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | 0.48200730 |
| 112 | Focal adhesion_Homo sapiens_hsa04510 | 0.47070046 |
| 113 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.46790151 |
| 114 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.45869069 |
| 115 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45156606 |
| 116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.43124616 |
| 117 | Phototransduction_Homo sapiens_hsa04744 | 0.42796938 |
| 118 | Axon guidance_Homo sapiens_hsa04360 | 0.41781911 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41762728 |
| 120 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.41621444 |
| 121 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.41574407 |
| 122 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39879810 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39555951 |
| 124 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.39121551 |
| 125 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37821459 |
| 126 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37289776 |
| 127 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37094507 |
| 128 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.36642601 |

